Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
June 19, 2025 01:00 ET | Source: Addex Therapeutics Strong cash position…
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
June 18, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June…
Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#Biotech--Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle…
Despite Global Headwinds, Domestic Demand and Prudent Investment drive Small Business Optimism- ASSOCHAM-Dun & Bradstreet’s Small Business Confidence Index
MUMBAI, India, June 13, 2025 /PRNewswire/ -- ASSOCHAM along with Dun & Bradstreet,…
Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the…
Ned Introduces Spotlight, a Lightweight Solution for Instant Cash Flow Insight
Spotlight delivers real-time cash flow visibility so lenders can reduce risk, cut…
Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
46% reduction in the risk of disease progression or death, and 27%…
Addex Convenes Annual General Meeting 2025
June 03, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June…